Lumexa Imaging Holdings Q4 Adj. EPS $(0.20) Misses $0.07 Estimate, Sales $267.734M Beat $261.206M Estimate

Lumexa Imaging Holdings (NASDAQ: LMRI) reported a Q4 adjusted EPS of $(0.20), missing the analyst estimate of $0.07 by 381.69%. This represents a 44.44% increase in losses compared to $(0.36) per share from the same period last year. The company achieved quarterly sales of $267.734 million, exceeding the expected $261.206 million by 2.50%, and marking a 7.95% increase from $248.028 million in the previous year.